Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nikhil Avalaskar"'
Autor:
Barbara Bolgiano, Eilís Moran, Nicola J. Beresford, Fang Gao, Rory Care, Trusha Desai, Ida Karin Nordgren, Timothy R. Rudd, Ian M. Feavers, Prashant Bore, Sushil Patni, Vinay Gavade, Asha Mallya, Sameer Kale, Pankaj Sharma, Sunil K. Goel, Sunil Gairola, Suhas Hattarki, Nikhil Avalaskar, Annamraju D. Sarma, Marc LaForce, Neil Ravenscroft, Lakshmi Khandke, Mark R. Alderson, Rajeev M. Dhere, Sambhaji S. Pisal
Publikováno v:
Pathogens, Vol 10, Iss 8, p 928 (2021)
Towards achieving the goal of eliminating epidemic outbreaks of meningococcal disease in the African meningitis belt, a pentavalent glycoconjugate vaccine (NmCV-5) has been developed to protect against Neisseria meningitidis serogroups A, C, Y, W and
Externí odkaz:
https://doaj.org/article/ed955ddea0f7409d8a5231da50c31f7e
Autor:
Fadima C. Haidara, Ama Umesi, Samba O. Sow, Magnus Ochoge, Fatoumata Diallo, Abdulazeez Imam, Youssouf Traore, Lucy Affleck, Moussa F. Doumbia, Bubacarr Daffeh, Mamoudou Kodio, Oghenebrume Wariri, Awa Traoré, Edrissa Jallow, Beate Kampmann, Dhananjay Kapse, Prasad S. Kulkarni, Asha Mallya, Sunil Goel, Pankaj Sharma, Annamraju D. Sarma, Nikhil Avalaskar, F. Marc LaForce, Mark R. Alderson, Abdi Naficy, Steve Lamola, Yuxiao Tang, Lionel Martellet, Nancy Hosken, Evangelos Simeonidis, Jo Anne Welsch, Milagritos D. Tapia, Ed Clarke
Publikováno v:
New England Journal of Medicine. 388:1942-1955
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c448d2a062e124d9a5c10b412af59948
https://doi.org/10.1056/nejmoa2214924
https://doi.org/10.1056/nejmoa2214924
Autor:
Rajeev M. Dhere, Eilís Moran, Asha D. Mallya, Fang Gao, Marc LaForce, Lakshmi Khandke, Annamraju D. Sarma, Sameer Manohar Kale, Trusha Desai, Pankaj Sharma, Ida Karin Nordgren, Rory Care, Sushil Patni, Vinay Gavade, Timothy R. Rudd, Sunil Goel, Ian M. Feavers, Mark R. Alderson, Sunil Gairola, Suhas Hattarki, Nikhil Avalaskar, Prashant Bore, Sambhaji Shankar Pisal, Nicola J. Beresford, Neil Ravenscroft, Barbara Bolgiano
Publikováno v:
Pathogens
Pathogens, Vol 10, Iss 928, p 928 (2021)
Volume 10
Issue 8
Pathogens, Vol 10, Iss 928, p 928 (2021)
Volume 10
Issue 8
Towards achieving the goal of eliminating epidemic outbreaks of meningococcal disease in the African meningitis belt, a pentavalent glycoconjugate vaccine (NmCV-5) has been developed to protect against Neisseria meningitidis serogroups A, C, Y, W and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90a229941dcc62340e1b28fc0280f5c1
https://pubmed.ncbi.nlm.nih.gov/34451392
https://pubmed.ncbi.nlm.nih.gov/34451392